Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
95,230,658
-
Share change
-
+20,778,251
-
Total reported value
-
$7,372,384,721
-
Put/Call ratio
-
256%
-
Price per share
-
$77.44
-
Number of holders
-
439
-
Value change
-
+$1,588,421,424
-
Number of buys
-
201
-
Number of sells
-
220
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2020
As of 31 Mar 2020,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
439 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,230,658 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, BANK OF AMERICA CORP /DE/, BARCLAYS PLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and BANK OF NOVA SCOTIA.
This page lists
439
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.